EN | UA
EN | UA

Help Support

Back

Loxoprofen: A review in pain and inflammation

Loxoprofen: A review in pain and inflammation Loxoprofen: A review in pain and inflammation
Loxoprofen: A review in pain and inflammation Loxoprofen: A review in pain and inflammation

Loxoprofen is a prodrug-type NSAID that is available in several formulations, including 60 mg tablets, 100 mg hydrogel patches and 50 or 100 mg tape.

See All

Key take away

The significance of loxoprofen has been deduced in this study for pain and inflammation. This review has emphasized on the analgesic activity of loxoprofen and how the drug is better than NSAIDs due to its potential of lowering many complications concerned with the oral NSAID use.

Background

Loxoprofen is a prodrug-type NSAID that is available in several formulations, including 60 mg tablets, 100 mg hydrogel patches and 50 or 100 mg tape.

Method

In active comparator-controlled trials, oral loxoprofen therapy (ranging from 2 days to 6 weeks’ duration depending on the pain type) provided analgesic efficacy that generally did not significantly differ from that of celecoxib for postoperative pain or frozen shoulder, ibuprofen for knee osteoarthritis or naproxen for lumbar pain. In double-blind, double-dummy, multicentre trials, loxoprofen hydrogel patches were non-inferior to oral loxoprofen with regard to rates of final overall symptomatic improvement over 1–4 weeks in patients with knee osteoarthritis, myalgia or trauma-induced swelling and pain. Loxoprofen hydrogel patches were also non-inferior to other commercially available patches (ketoprofen and indomethacin) over 2 or 4 weeks in patients with knee osteoarthritis or myalgia in open-label studies.

Result

Oral and topical loxoprofen were generally well tolerated in clinical trials.

Conclusion

Thus, loxoprofen is a useful analgesic option for patients with pain and inflammation, with topical loxoprofen potentially reducing the risk of gastrointestinal, cardiovascular and renal complications associated with oral NSAID use.

Source:

Clin Drug Investig. 2016 Sep;36(9):771-81

Article:

Loxoprofen: A Review in Pain and Inflammation

Authors:

Sarah L. Greig, Karly P. Garnock-Jones

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: